Singapore markets close in 2 hours 47 minutes

Aadi Bioscience, Inc. (AADI)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
4.7800+0.0700 (+1.49%)
At close: 04:00PM EST
4.7800 0.00 (0.00%)
After hours: 04:01PM EST
Full screen
Trade prices are not sourced from all markets
Previous close4.7100
Open4.7100
Bid0.0000 x 800
Ask0.0000 x 1300
Day's range4.7000 - 4.9361
52-week range3.8800 - 13.5200
Volume156,263
Avg. volume109,325
Market cap117.234M
Beta (5Y monthly)0.45
PE ratio (TTM)N/A
EPS (TTM)-2.3200
Earnings date08 Nov 2023
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est33.00
  • PR Newswire

    Aadi Bioscience Reports Financial Results for the Third Quarter 2023 and Provides Corporate Update

    Aadi Bioscience, Inc. (NASDAQ: AADI), a biopharmaceutical company focused on developing and commercializing precision therapies for genetically defined cancers with alterations in mTOR pathway genes, today announced financial results for the quarter ended September 30, 2023, and highlighted recent corporate progress.

  • PR Newswire

    Aadi Bioscience to Participate in Jefferies London Healthcare Conference

    Aadi Bioscience, Inc. (NASDAQ: AADI), a commercial-stage biopharmaceutical company focused on developing and commercializing precision therapies for genetically-defined cancers with alterations in mTOR pathway genes, announced today participation in the Jefferies London Healthcare Conference, taking place November 14-16, 2023, in London. Dave Lennon, Ph.D., President and CEO, will participate in a fireside chat on Tuesday, November 14, 2023, at 8:30 am GMT.

  • PR Newswire

    Aadi Bioscience to Report Third Quarter 2023 Results and Operational Update

    Aadi Bioscience, Inc. (NASDAQ: AADI), a commercial-stage biopharmaceutical company focused on developing and commercializing precision therapies for genetically-defined cancers with alterations in mTOR pathway genes, today announced that it will host a conference call and live webcast on Wednesday, November 8, 2023 at 8:30 am ET (5:30 am PT) to report third quarter 2023 financial results and provide an operational update.